BIS -2x ProShares UltraShort NASDAQ Biotechnology

BEAR ETF standard · Issuer ProShares · Tracks NASDAQ Biotechnology (IBB) · Listed 2010-04-06

Implied AUM
$1.9M
shares out × price
Last close
$11.40
20261118
30-day avg volume
11,347
BIS realized257d
-43.38%
what holders actually earned
Theoretical -2x
-44.69%
-2x × NASDAQ Biotechnology's return
Decay gap
1.31%
ahead of a clean -2× — rare, trend-driven

Realized vs theoretical -2x NASDAQ Biotechnology

Over 257 trading days: BIS -43.38% · Theoretical -2× -44.69% · Decay gap 1.31% (positive carry)

Pair counterpart: BIB (+2x bull, ProShares Ultra NASDAQ Biotechnology)
Shorting both legs of a daily-reset bull/bear pair captures their combined decay over time. It isn't free money — the edge depends on borrow rates (often punitive on the bear leg) and assignment risk on hard-to-borrow shares.

Other leveraged products on NASDAQ Biotechnology

1
SymbolFactorDirectionIssuerNameImplied AUM30d volumeOptions
BIB +2x BULLProSharesProShares Ultra NASDAQ Biotechnology $95.4M 8,181 ✓

How BIS works

BIS targets -2x the daily return of NASDAQ Biotechnology — not the return over longer windows. It rebalances every day, so over weeks and months its result drifts away from -2x × the index, usually downward when the market chops around.

The maths: the drag is roughly −½ × N × (N−1) × σ² per period (N = leverage, σ = the index's volatility). For a -2x fund on an index with 25% annual volatility that is several percent a year before fees — the red line above is that drag measured.

Short-term trades (a day or a few) are what these funds are built for. Premium sellers like their rich option IV — see the quote page. Multi-day directional bets work in strong trends and get eaten in chop.

Not investment advice.